Clinical Edge Journal Scan

Obesity and Family History of Cancer Raise Breast Cancer Risk


 

Key clinical point: The coexistence of obesity and family history of cancer significantly increased the risk for breast cancer (BC) in women, suggesting that weight management is important in women with a family history of cancer.

Major finding: The risk for BC was significantly higher in women with vs without a family history of BC (adjusted hazard ratio [aHR] 1.63; 95% CI 1.22-2.49). The risk was further elevated in women with a body mass index (BMI) 24 kg/m 2 and a family history of cancer vs women with BMI < 24 kg/m 2 and no family history of cancer (adjusted hazard ratio 2.06; 95% CI 1.39-3.06).

Study details: Findings are from a population-based prospective cohort study that included 15,055 women, of which 4210 women had a family history of cancer.

Disclosures: This study was supported by the Nature Science Foundation of Minhang district, Shanghai, China. The authors declared no conflicts of interest.

Source: Cao J, Li J, Zhang Z, et al. Interaction between body mass index and family history of cancer on the risk of female breast cancer. Sci Rep. 2024;14:4927 (Feb 28). doi: 10.1038/s41598-024-54762-x Source

Recommended Reading

Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
MDedge Hematology and Oncology
New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety Concerns
MDedge Hematology and Oncology
Does worsening metabolic syndrome increase the risk of developing cancer?
MDedge Hematology and Oncology
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?
MDedge Hematology and Oncology
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
MDedge Hematology and Oncology
MRI Surveillance Reduces Breast Cancer Mortality in Women with BRCA1 Sequence Variation
MDedge Hematology and Oncology
Hyperbaric Oxygenation May Reduce Late Local Toxic Effects After Breast Cancer Irradiation
MDedge Hematology and Oncology
Enobosarm Shows Antitumor Activity in ER+ Advanced BC in Phase 2
MDedge Hematology and Oncology
Doxorubicin May Raise Breast Cancer Risk in Hodgkin Lymphoma Survivors
MDedge Hematology and Oncology
Breast-Conserving Surgery Does Not Increase Locoregional Recurrence in TNBC
MDedge Hematology and Oncology